Right Turn: Some views on drug discovery

Author: Lisa Willemse, 01/10/14

>
Earlier this week, we tweeted some articles published online at Scientific American that provide some perspectives on the complexity and high costs of drug discovery – so far, two have been published, here and here. The tweet elicited a thought-provoking response from one of our researchers, Christopher McCabe:

tweetJan7drugdisc

tweetJan7drugdisc

This is one of many possible ways to view (either in support or in criticism of) the drug discovery process, a topic that merits a great deal of discussion, and not merely because of the massive investments made by Big Pharma. In the spirit of our Right Turn series (see description at bottom), here’s another perspective, one that posits an open source strategy:

We invite you to share your views on this complicated topic in the comments section.

Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.

As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.

The following two tabs change content below.
Lisa Willemse

Lisa Willemse

Lisa is a science communicator with 15+ years' experience in the fields of regenerative medicine, child development and technology. She launched this blog (first as the Stem Cell Network Blog) in 2009, and served as co-editor until April 2015. She is currently the Senior Communications Advisor for the Ontario Institute for Regenerative Medicine and has recently contributed to Motherboard, Science Borealis and the Genome Alberta and Canadian Blood Services blogs. Follow her on Twitter and Medium @WillemseLA.
Tags: , , , , ,

2 Responses

Leave a Reply

*
*